Establishes maximum fair prices for certain prescription drugs in Minnesota, prohibiting manufacturers from accepting higher payments.
This bill sets the maximum fair price for certain prescription drugs in Minnesota, aligning with the United States Department of Health and Human Services' established prices. It prohibits manufacturers from accepting payments higher than these prices for drugs intended for use in the state. Additionally, it mandates that health plans and pharmacy benefit managers provide financial information to the Prescription Drug Affordability Board. The bill also prohibits manufacturers from withdrawing drugs from sale to avoid these price limitations without proper notice.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.